-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TD-5202 in Crohn’s Disease (Regional Enteritis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TD-5202 in Crohn's Disease (Regional Enteritis) Drug Details: TD-5202 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOM-1311 in Phenylketonuria (PKU)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SOM-1311 in Phenylketonuria (PKU) Drug Details:SOM-1311 (SOM-0011) is under development for the treatment of phenylketonuria. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Denosumab Biosimilar in Humoral Hypercalcemia of MalignancyDrug Details:denosumab biosimilar (GP-2411)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ripasudil Hydrochloride Hydrate in Fuchs Endothelial Corneal Dystrophy (FECD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ripasudil Hydrochloride Hydrate in Fuchs Endothelial Corneal Dystrophy (FECD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ripasudil Hydrochloride Hydrate in Fuchs Endothelial Corneal Dystrophy...
-
Product Insights
Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Contact Lenses Pipeline Market Report Overview A contact lens is a corrective, cosmetic, or therapeutic lens that is placed on the cornea of the eye. The Contact Lenses pipeline market research report provides comprehensive information about the contact lens pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Soft Contact Lenses ·       Rigid Gas Permeable Contact Lenses Key Territories ·       The US...
-
Track & Monitor
Travel and Tourism Venture Capital Investments in Q2 2023
GlobalData's Travel & Tourism (T&T) VentureView report provides detailed coverage of the global venture capital investment activity in Travel & Tourism industry in Q2 2023, covering key insights and trends.
-
Trinity Health/ Universal Health Svs – Southridge Behavioral Hospital – Michigan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Trinity Health/ Universal Health Svs – Southridge Behavioral Hospital – Michigan report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Idaho SVS – Boise Veterans Home – Idaho
Equip yourself with the essential tools needed to make informed and profitable decisions with our Idaho SVS - Boise Veterans Home - Idaho report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...